Introduction {#Sec1}
============

Serial lactate measurements provide a valuable tool to risk-stratify patients, determine the presence of ongoing tissue hypoperfusion, and potentially evaluate efficacy of therapeutic interventions. Prior studies have shown lactate clearance to be a valuable predictor of patient outcomes, however some have defined adequate change in lactate by a decrease from baseline by 10% whereas others considered an absolute reduction to lactate \< 4mmol/L. We hypothesize that a serial absolute lactate \< 4mmol/L after initial resuscitation will be as effective a predictor of future mortality as a change by 10%.

Objectives {#Sec2}
==========

To compare the diagnostic characteristics of an absolute serial lactate \< 4 mmol/L after resuscitation with the more traditional definition (\>10% decrease in serum lactate).

Methods {#Sec3}
=======

Single-center retrospective study of patients presenting to an urban tertiary care Emergency Department (ED) with lactate \>4mmol/L and suspected infection. Continuous data was analyzed using a one-way ANOVA, whereas categorical data was compared using Fisher\'s exact test. Patients were stratified by lactate clearance using the traditional definition (\>10% decrease in serum lactate) as well as a novel definition (second lactate \< 4mmol/L) and compared.

Results {#Sec4}
=======

Median initial lactate was 5.2mmol/L \[IQR 4.4-6.8\]. The average decrease in serum lactate was 26.7% \[2.3-44.4\]. In-hospital mortality was 26.7%. 109/161 (67.7%) patients had \>10% decrease in serum lactate, whereas 76/161 (47.2%) cleared lactate to \< 4mmol/L. The average amount of crystalloid fluid resuscitation received was 2,970 ml, and the average time between lactate values was 181 minutes. Among patients who cleared lactate by at least 10%, mortality was 21.1% while those who did not clear their lactate by 10% had 38.5% mortality (p = 0.02). The negative predictive value for in-hospital mortality among those who clear their lactate by 10% was 78.9% \[95% CI 69.8-85.9\], sensitivity was 46.5% \[95% CI: 31.5-62.2\] and specificity was 72.9% \[95% CI: 63.8-80.5\]. Among patients who cleared their lactate to \< 4mmol/L, mortality was 14.5%, while those who did not clear their lactate to \< 4mmol/L had a mortality of 37.6% (p = 0.001). The negative predictive value for in-hospital mortality among those who clear lactate to \< 4mmol/L was 85.5% \[95% CI 75.2-92.2\], sensitivity was 74.4% \[58.5-86.0\] and specificity was 55.1% \[45.7-64.2\].

Conclusions {#Sec5}
===========

A serial lactate \< 4mmol/L as compared to \>10% change has improved negative predictive value for in-hospital mortality and may provide more utility for risk stratification, assessment of response to therapy, and potentially clinical decision-making.
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Dr. Donnino, the Primary Investigator, is supported by NHLBI 1K02HL107447-01A1 and Dr. Cocchi is supported by AHA 15SDG22420010.Table 1Baseline CharacteristicsLactate decrease \<10% n = 52 (32.3)Lactate decrease \> 10% n = 109 (67.7)Serial Lactate \> 4mmol/L n = 85 (52.8)Serial Lactate \<4mmol/L n = 76 (47.2)Overall**Age**67.2 + 18.469.3 +15.268.4+17.969.0+14.468.6+16.3**Initial Lactate, mmol/L**5.25 \[4.4-7.1\]5.2 \[4.4-6.7\]6 \[4.9-8.6\]4.7 \[4.3-5.3\]5.2\[4.4-6.8\]**% Decrease in Lactate**0.0 \[-13.3-2.26\]37.3 \[25.6-52.7\]3.9\[-3.7-21.0\]44.4\[32.4-58.1\]26.7\[2.3-44.4\]**Time between lactate values, minutes**168 +109.7188+80.2163+99.5202+75.9181+90.9**Volume Crystalloid in 3 hours, ml**2971+19312969+14993080+18652850+13582970+1640**Initial Systolic Blood Pressure**105+31.0100+23.6105.9+28.797.8+22.7102.0+26.2**Vasopressors Use within 3 hours**22 (42.3)32 (29.4)35 (41.2)19 (25.0)54 (33.5)**ICU LOS, days**2.1 \[1.1-4.6\]2.2 \[1.3-5.9\]2.7 \[1.2-5.9\]1.9\[1.1-5.4\]2.2\[1.1-5.7\]**In-Hospital Mortality**20 (38.5)23 (21.1)32 (37.6)11 (14.5)43 (26.7)Table 2Comparison based on Lactate ClearanceLactate decrease \<10%Lactate decrease \> 10%P-valueSerial Lactate \> 4mmol/LSerial Lactate \<4mmol/LP-value**N**52109-8576-**Initial Lactate, mmol/L**6.15.90.436.84.9\< 0.0001**Volume Crystalloid in 3 hours, ml**2971.72969.40.992850.53080.60.39**Vasopressors within 3 hours**22 (42.3)32 (29.4)0.1135 (41.2)19 (25.0)0.04**In-hospital Mortality**20 (38.5)23 (21.1)0.0232 (37.7)11 (14.5)0.001
